Switzerland· 63182001

Abraxane

A paclitaxel product containing paclitaxelum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01CD01

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAbraxaneATCL01CD01REGISTER NO.63182001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Paclitaxel is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CD01 (paclitaxel), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Paclitaxel · ATC L01CD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paclitaxel costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.61 in Czechia to $19.82 in Switzerland — a ×32 gap.

  • Switzerland: $19.82 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Paclitaxel · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$19.82
  • CZ Czechia$0.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
paclitaxelum
Manufacturer
—
Country
Switzerland (CH)
ATC code
L01CD01
ATC class
Paclitaxel
Defined daily dose
15 mg, P
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680631820012
    Durchstf 1 Stk
    CHF 332.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

651 interactions on record for paclitaxel.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paclitaxel · interactions on record

651 records

  • 41 severe
  • 302 moderate
  • 17 minor
  • 291 info

Most severe, free to view

  • SaquinavirJ05AE01severe
  • IndinavirJ05AE02severe
  • RitonavirJ05AE03severe
  • NelfinavirJ05AE04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paclitaxel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paclitaxel products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Apacross, Bugvi
  • Belgium · Apacross, Bugvi
  • Bulgaria · Алсикроса, Паклитаксел Акорд
  • Cyprus · Paclitaxel Accord, Paclitaxel Hospira
  • Czechia · Alsicrosa, Paclitaxel Ebewe
  • Germany · Apacross, Axitaxel
  • Denmark · Apacross, Bugvi
  • Estonia · Paclitaxel Accord, Paclitaxel Ebewe
  • Spain · Apacross, Bugvi
  • Finland · Apacross, Pacligen
  • France · Bugvi, Paclitaxel Ahcl
  • United Kingdom (Northern Ireland) · Apacross, Paclitaxel
  • Greece · Biotaxel, Paclitaxel Hospira
  • Croatia · Abutrax, Alsicrosa
  • Hungary · Bugvi, Paclitaxel Accord
  • Ireland · Apacross, Paclitaxel
  • Iceland · Abraxane, Apexelsin
  • Italy · Abutrax, Apacross
  • Liechtenstein · Abraxane, Apexelsin
  • Lithuania · Paclitaxel Accord, Paclitaxel Ebewe
  • Luxembourg · Bugvi, Paclitaxel Accord Healthcare
  • Latvia · Paclitaxel Accord, Paclitaxel Kabi
  • Malta · Paclitaxel Accord Healthcare, Paclitaxel Hospira
  • Netherlands · Abutrax, Apacross
  • Norway · Abraxane, Apacross
  • Poland · Paclitaxel Ebewe, Paclitaxel Kabi
  • Portugal · Apacross, Paclitaxel Accord
  • Romania · Bugvi, Paclitaxel Accord
  • Sweden · Apacross, Bugvi
  • Slovenia · Alsicrosa, Paclitaxin
  • Slovakia · Paclitaxel Accord, Paclitaxel Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f60e1616-de8e-4a73-ba87-57cd379ec2b2
GET /v1/drugs/f60e1616-de8e-4a73-ba87-57cd379ec2b2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "paclitaxelum (paclitaxelum-albuminum) 100 mg",
  "valid_from": "2015-04-01",
  "limitations": "[{\"description\":\"<b>Adenokarzinom des Pankreas</b><br>\\nIn Kombination mit Gemcitabin, für die Erstlinienbehandlung von Patienten mit lokal fortgeschrittenem, nicht resezierbarem oder metastasiertem Adenokarzinom des Pankreas.<br><br>\\n\\n<b>Behandlung des metastasierenden Mammakarzinoms</b><br>\\nNach vorgängiger Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.<br>\\nBehandlung des metastasierenden Mammakarzinoms nach Versagen einer Chemotherapie oder Rezidiv innert 6 Monaten nach adjuvanter Chemotherapie. In der Vortherapie muss ein Anthrazyklin enthalten gewesen sein, es sei denn, es bestand eine Kontraindikation. Die Therapie muss als Monotherapie verabreicht werden. Eine Kombination mit Biologika oder antihormoneller Therapie ist nicht möglich. Abraxane darf nicht als Alternative für andere Paclitaxel-Formulierungen verwendet werden, es sei denn die Behandlung mit anderen Paclitaxel-Formulierungen ist ungeeignet.<br>\\n\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2015-04-01\",\"validTo\":null}]",
  "galenic_form": "Trockensub 100 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2015-04-01",
  "self_retention_pct": 40
}

See everything about paclitaxel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.